Capital International Investors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $159M | Buy |
|
|||||
2024
Q4 | $264M | Buy |
|
|||||
2024
Q3 | $124M | Sell |
|
|||||
2024
Q2 | $200M | Buy |
|
|||||
2024
Q1 | $139M | Buy |
|
|||||
2023
Q4 | $132M | Sell |
|
|||||
2023
Q3 | $145M | Buy |
|
|||||
2023
Q2 | $366M | Buy |
|
|||||
2023
Q1 | $460M | Sell |
|
|||||
2022
Q4 | $583M | Buy |
|
|||||
2022
Q3 | $602M | Buy |
|
|||||
2022
Q2 | $550M | Sell |
|
|||||
2022
Q1 | $940M | Buy |
|
|||||
2021
Q4 | $851M | Buy |
|
|||||
2021
Q3 | $1.23B | Buy |
|
|||||
2021
Q2 | $2.03B | Buy |
|
|||||
2021
Q1 | $1.21B | Buy |
|
|||||
2020
Q4 | $1.43B | Buy |
|
|||||
2020
Q3 | $913M | Buy |
|
|||||
2020
Q2 | $207M | Buy |
|
|||||
2020
Q1 | $172M | Buy |
|
|||||
2019
Q4 | $116M | Buy |
|
|||||
2019
Q3 | $48.3M | Hold |
|
|||||
2019
Q2 | $40.9M | Hold |
|
|||||
2019
Q1 | $31.1M | Buy |
|
|||||
2018
Q4 | $11M | Buy |
|